VEGFA and neoplasm: To identify the molecule(s) that contributes to the acquired resistance to anti-VEGF therapy, we engineered human- or mouse-specific primers to determine the differential changes in the tumour (human) and/or stromal (mouse) gene expression by performing a quantitative PCR (qPCR) analysis.